Abstract
Get full access to this article
View all access options for this article.
References
1.
Cooper
DS
,
Doherty
GM
,
Haugen
BR
,
Kloos
RT
,
Lee
SL
,
Mandel
SJ
,
Mazzaferri
EL
,
McIver
B
,
Pacini
F
,
Schlumberger
M
,
Sherman
SI
,
Steward
DL
,
Tuttle
RM
. 2009 . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer . Thyroid , 19 :1167 –1214 .
2.
Cooper
DS
,
Doherty
GM
,
Haugen
BR
,
Kloos
RT
,
Lee
SL
,
Mandel
SJ
,
Mazzaferri
EL
,
McIver
B
,
Sherman
SI
,
Tuttle
RM
. 2006 . American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer . Thyroid , 16 :109 –142 .
3.
Hay
ID
,
Hutchinson
ME
,
Gonzalez-Losada
T
,
McIver
B
,
Reinalda
ME
,
Grant
CS
,
Thompson
GB
,
Sebo
TJ
,
Goellner
JR
. 2008 . Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period . Surgery , 144 :980 –987 discussion 987–988.
4.
Ross
DS
,
Litofsky
D
,
Ain
KB
,
Bigos
T
,
Brierley
JD
,
Cooper
DS
,
Haugen
BR
,
Jonklaas
J
,
Ladenson
PW
,
Magner
J
,
Robbins
J
,
Skarulis
MC
,
Steward
DL
,
Maxon
HR
,
Sherman
SI
. 2009 . Recurrence after treatment of micropapillary thyroid cancer . Thyroid , 19 :1043 –1048 .
5.
Buffet
C
,
Golmard JL
Hoang C
,
Tresallet
C
,
Du Pasquier Fediaevsky
L
,
Fierrard
H
,
Aurengo
A
,
Menegaux
F
,
Leenhardt
L
. 2012 . Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma . Eur J Endocrinol , 167 :267 –275 .
6.
Ardito
G
,
Revelli
L
,
Giustozzi
E
,
Salvatori
M
,
Fadda
G
,
Ardito
F
,
Avenia
N
,
Ferretti
A
,
Rampin
L
,
Chondrogiannis
S
,
Colletti
PM
,
Rubello
D
. 2013 . Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy . Clin Nucl Med , 38 :25 –28 .
7.
Schvartz
C
,
Bonnetain
F
,
Dabakuyo
S
,
Gauthier
M
,
Cueff
A
,
Fieffé
S
,
Pochart
JM
,
Cochet
I
,
Crevisy
E
,
Dalac
A
,
Papathanassiou
D
,
Toubeau
M
. 2012 . Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients . J Clin Endocrinol Metab , 97 :1526 –1535 .
8.
Schlumberger
M
,
Catargi
B
,
Borget
I
,
Deandreis
D
,
Zerdoud
S
,
Bridji
B
,
Bardet
S
,
Leenhardt
L
,
Bastie
D
,
Schvartz
C
,
Vera
P
,
Morel
O
,
Benisvy
D
,
Bournaud
C
,
Bonichon
F
,
Dejax
C
,
Toubert
ME
,
Leboulleux
S
,
Ricard
M
,
Benhamou E; Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence
Trial
. 2012 . Strategies of radioiodine ablation in patients with low-risk thyroid cancer . N Engl J Med , 366 :1663 –1673 .
9.
Mallick
U
,
Harmer
C
,
Yap
B
,
Wadsley
J
,
Clarke
S
,
Moss
L
,
Nicol
A
,
Clark
PM
,
Farnell
K
,
McCready
R
,
Smellie
J
,
Franklyn
JA
,
John
R
,
Nutting
CM
,
Newbold
K
,
Lemon
C
,
Gerrard
G
,
Abdel-Hamid
A
,
Hardman
J
,
Macias
E
,
Roques
T
,
Whitaker
S
,
Vijayan
R
,
Alvarez
P
,
Beare
S
,
Forsyth
S
,
Kadalayil
L
,
Hackshaw
A
. 2012 . Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer . N Engl J Med , 366 :1674 –1685 .
10.
Clerc
J
,
Bienvenu-Perrard
M
,
de Malleray
CP
,
Dagousset
F
,
Delbot
T
,
Dreyfuss
M
,
Groussin
L
,
Marlowe
RJ
,
Leger
FA
,
Chevalier
A
. 2012 . J Clin Endocrinol Metab , 97 :871 –880 .
11.
Schlumberger
M
,
Leboulleux
S
,
Borget
I
. 2012 . Radioiodine ablation in low-risk thyroid cancer . N Engl J Med , 367 :672 –675 .